For ciprofloxacin, an increasing trend was found after the change-point in the sensitivity analysis, but not in the primary analysis.
← all excerpts
Impact of changing reimbursement criteria on the use of fluoroquinolones in Belgium.
1
—
—
For ciprofloxacin, an increasing trend was found after the change-point in the sensitivity analysis, but not in the primary analysis.